Sana Biotechnology Inc vs Nuscale Power Corporation — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Nuscale Power Corporation trades at $8.83 (market cap $2.76B). The key difference: Nuscale Power Corporation is far larger — about 3.2× Sana Biotechnology Inc's market cap, and Sana Biotechnology Inc is trading nearer its 52-week high, Nuscale Power Corporation nearer its low. Which is the better fit depends on your goals.
| SANA | SMR | |
|---|---|---|
Market Cap | $873.84M | $2.76B |
Sector | Health | Utilities |
52-Week High | $5.92 | $53.43 |
52-Week Low | $2.68 | $7.64 |
Enterprise Value | $848.03M | $1.87B |
Trailing returns across standard periods
Latest headlines on both assets
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →NuScale Power Corporation is a leading developer of Small Modular Reactor (SMR) technology. The company's flagship product is a light water reactor SMR designed to generate clean, reliable, and scalable nuclear power. NuScale's technology is poised to address the global demand for carbon-free energy by offering a safer, smaller, and more flexible alternative to traditional large-scale nuclear power plants, with applications in electricity generation, desalination, and process heat.
Read more on SMR →